Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosis.
Gudmundsson E, Zhao A, Mogulkoc N, van Beek F, Goos T, Brereton CJ, Veltkamp M, Chapman R, van Es HW, Garthwaite H, Gholipour B, Heightman M, Nair A, Pontoppidan K, Savas R, Ahmed A, Vermant M, Unat O, Procter A, De Sadeleer L, Denneny E, Wallis T, Duncan M, Taylor M, Verleden S, Janes SM, Alexander DC, Wells AU, Porter J, Jones MG, Stewart I, van Moorsel CHM, Wuyts W, Jacob J. Gudmundsson E, et al. Among authors: jones mg. ERJ Open Res. 2023 Mar 27;9(2):00637-2022. doi: 10.1183/23120541.00637-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 37009018 Free PMC article.
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
Johannson KA, Strâmbu I, Ravaglia C, Grutters JC, Valenzuela C, Mogulkoc N, Luppi F, Richeldi L, Wells AU, Vancheri C, Kreuter M; Erice ILD Working Group. Johannson KA, et al. Lancet Respir Med. 2017 Jul;5(7):591-598. doi: 10.1016/S2213-2600(17)30219-9. Lancet Respir Med. 2017. PMID: 28664861 Review.
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice.
Fletcher SV, Jones MG, Renzoni EA, Parfrey H, Hoyles RK, Spinks K, Kokosi M, Kwok A, Warburton C, Titmuss V, Thillai M, Simler N, Maher TM, Brereton CJ, Chua F, Wells AU, Richeldi L, Spencer LG. Fletcher SV, et al. Among authors: jones mg. ERJ Open Res. 2018 Oct 19;4(4):00049-2018. doi: 10.1183/23120541.00049-2018. eCollection 2018 Oct. ERJ Open Res. 2018. PMID: 30364342 Free PMC article.
Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis.
Hill C, Li J, Liu D, Conforti F, Brereton CJ, Yao L, Zhou Y, Alzetani A, Chee SJ, Marshall BG, Fletcher SV, Hancock D, Ottensmeier CH, Steele AJ, Downward J, Richeldi L, Lu X, Davies DE, Jones MG, Wang Y. Hill C, et al. Among authors: jones mg. Cell Death Dis. 2019 Aug 7;10(8):591. doi: 10.1038/s41419-019-1820-x. Cell Death Dis. 2019. PMID: 31391462 Free PMC article.
Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome.
Jacob J, Aksman L, Mogulkoc N, Procter AJ, Gholipour B, Cross G, Barnett J, Brereton CJ, Jones MG, van Moorsel CH, van Es W, van Beek F, Veltkamp M, Desai SR, Judge E, Burd T, Kokosi M, Savas R, Bayraktaroglu S, Altmann A, Wells AU. Jacob J, et al. Among authors: jones mg. Thorax. 2020 Aug;75(8):648-654. doi: 10.1136/thoraxjnl-2019-213865. Epub 2020 Apr 28. Thorax. 2020. PMID: 32345689 Free PMC article.
Time taken from primary care referral to a specialist centre diagnosis of idiopathic pulmonary fibrosis: an opportunity to improve patient outcomes?
Brereton CJ, Wallis T, Casey M, Fox L, Pontopiddan K, Laws D, Graves J, Titmuss V, Kearney S, Evans S, Grove A, Hamid S, Richeldi L, O'Reilly KMA, Fletcher SV, Jones MG. Brereton CJ, et al. Among authors: jones mg. ERJ Open Res. 2020 Jul 20;6(2):00120-2020. doi: 10.1183/23120541.00120-2020. eCollection 2020 Apr. ERJ Open Res. 2020. PMID: 32714958 Free PMC article.
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?
Kalluri M, Luppi F, Vancheri A, Vancheri C, Balestro E, Varone F, Mogulkoc N, Cacopardo G, Bargagli E, Renzoni E, Torrisi S, Calvello M, Libra A, Pavone M, Bonella F, Cottin V, Valenzuela C, Wijsenbeek M, Bendstrup E; 3rd International Summit for ILD (ISILD), Erice collaborators listed below. Kalluri M, et al. Eur Respir Rev. 2021 May 25;30(160):210026. doi: 10.1183/16000617.0026-2021. Print 2021 Jun 30. Eur Respir Rev. 2021. PMID: 34039675 Free PMC article. Review.
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema.
Zhao A, Gudmundsson E, Mogulkoc N, Jones MG, van Moorsel C, Corte TJ, Romei C, Savas R, Brereton CJ, van Es HW, Jo H, De Liperi A, Unat O, Pontoppidan K, van Beek F, Veltkamp M, Hopkins P, Moodley Y, Taliani A, Tavanti L, Gholipour B, Nair A, Janes S, Stewart I, Barber D, Alexander DC, Wells AU, Jacob J. Zhao A, et al. Among authors: jones mg. ERJ Open Res. 2021 Aug 23;7(3):00316-2021. doi: 10.1183/23120541.00316-2021. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34435039 Free PMC article.
317 results